Christian Weyer Insider Trading $ICPT INTERCEPT PHARMACEUTICALS, INC.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Christian Weyer.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Christian Weyer. Christian Weyer is SVP, Research & Development in AMYLIN PHARMACEUTICALS INC ($AMLN) and EVP Research and Development in INTERCEPT PHARMACEUTICALS INC ($ICPT) and EVP, Research & Development in INTERCEPT PHARMACEUTICALS, INC. ($ICPT) and See Remarks in FATE THERAPEUTICS INC ($FATE).

Christian Weyer in INTERCEPT PHARMACEUTICALS, INC.

Trading Symbol: ICPT
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Christian Weyer: EVP, Research & Development, EVP Research and Development
Holdings: 27,341 shares
Current Value: $3,105,117
Latest Transaction: Apr 05 2021
$ICPT Market Capitalization: $2.80B
$ICPT Previous Close: $113.57

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Christian Weyer in INTERCEPT PHARMACEUTICALS, INC.

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, AMLN, FATE, ICPT

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Apr 05 2021ICPTINTERCEPT PHARMACE ...Weyer ChristianEVP, Research & Dev ...Payment of ExerciseF24.28461,11727,34127.4 K to 27.3 K (-0.17 %)
Jan 26 2021ICPTINTERCEPT PHARMACE ...Weyer ChristianEVP, Research & Dev ...Option ExerciseA29.4619,700580,36219,700
Jan 26 2021ICPTINTERCEPT PHARMACE ...Weyer ChristianEVP, Research & Dev ...GrantA0.0012,600027,74415.1 K to 27.7 K (+83.20 %)
Nov 30 2020ICPTINTERCEPT PHARMACE ...Weyer ChristianEVP, Research & Dev ...Payment of ExerciseF37.2735713,30515,97716.3 K to 16 K (-2.19 %)
Aug 31 2020ICPTINTERCEPT PHARMACE ...Weyer ChristianEVP, Research & Dev ...Payment of ExerciseF48.8135717,42516,38016.7 K to 16.4 K (-2.13 %)
Aug 31 2020ICPTINTERCEPT PHARMACE ...Weyer ChristianEVP, Research & Dev ...Payment of ExerciseF48.8135717,42516,38016.7 K to 16.4 K (-2.13 %)
Jul 06 2020ICPTINTERCEPT PHARMACE ...Weyer ChristianEVP, Research & Dev ...Payment of ExerciseF46.52462,14016,73716.8 K to 16.7 K (-0.27 %)
May 29 2020ICPTINTERCEPT PHARMACE ...Weyer ChristianEVP, Research & Dev ...Payment of ExerciseF74.4335726,57216,78317.1 K to 16.8 K (-2.08 %)
Apr 29 2020ICPTINTERCEPT PHARMACE ...Weyer ChristianEVP, Research & Dev ...SellS85.9518115,55717,14017.3 K to 17.1 K (-1.04 %)
Apr 03 2020ICPTINTERCEPT PHARMACE ...Weyer ChristianEVP, Research & Dev ...Payment of ExerciseF58.40462,68617,32117.4 K to 17.3 K (-0.26 %)
Feb 28 2020ICPTINTERCEPT PHARMACE ...Weyer ChristianEVP, Research & Dev ...SellS87.621139,90117,36717.5 K to 17.4 K (-0.65 %)
Feb 28 2020ICPTINTERCEPT PHARMACE ...Weyer ChristianEVP, Research & Dev ...Payment of ExerciseF85.3935730,48417,48017.8 K to 17.5 K (-2.00 %)
Jan 27 2020ICPTINTERCEPT PHARMACE ...Weyer ChristianEVP, Research & Dev ...Option ExerciseA99.667,900787,3147,900
Jan 27 2020ICPTINTERCEPT PHARMACE ...Weyer ChristianEVP, Research & Dev ...SellS94.0472367,99117,83718.6 K to 17.8 K (-3.90 %)
Jan 27 2020ICPTINTERCEPT PHARMACE ...Weyer ChristianEVP, Research & Dev ...GrantA0.004,800018,56013.8 K to 18.6 K (+34.88 %)
Jan 03 2020ICPTINTERCEPT PHARMACE ...Weyer ChristianEVP, Research & Dev ...Payment of ExerciseF123.92546,69213,76013.8 K to 13.8 K (-0.39 %)
Jan 03 2020ICPTINTERCEPT PHARMACE ...Weyer ChristianEVP, Research & Dev ...Payment of ExerciseF123.9236445,10713,81414.2 K to 13.8 K (-2.57 %)
Dec 30 2019ICPTINTERCEPT PHARMACE ...Weyer ChristianEVP, Research & Dev ...Option ExerciseM58.74543,1722,883
Dec 30 2019ICPTINTERCEPT PHARMACE ...Weyer ChristianEVP, Research & Dev ...Option ExerciseM59.1241624,59417,692
Dec 30 2019ICPTINTERCEPT PHARMACE ...Weyer ChristianEVP, Research & Dev ...SellS123.241,581194,84214,17815.8 K to 14.2 K (-10.03 %)
Dec 30 2019ICPTINTERCEPT PHARMACE ...Weyer ChristianEVP, Research & Dev ...BuyM58.74543,17215,75915.7 K to 15.8 K (+0.34 %)
Dec 30 2019ICPTINTERCEPT PHARMACE ...Weyer ChristianEVP, Research & Dev ...BuyM59.1241624,59415,70515.3 K to 15.7 K (+2.72 %)
Dec 02 2019ICPTINTERCEPT PHARMACE ...Weyer ChristianEVP, Research & Dev ...Option ExerciseM58.74523,0542,937
Dec 02 2019ICPTINTERCEPT PHARMACE ...Weyer ChristianEVP, Research & Dev ...Option ExerciseM59.1287551,73018,108
Dec 02 2019ICPTINTERCEPT PHARMACE ...Weyer ChristianEVP, Research & Dev ...Payment of ExerciseF109.1635738,97015,28915.6 K to 15.3 K (-2.28 %)
Dec 02 2019ICPTINTERCEPT PHARMACE ...Weyer ChristianEVP, Research & Dev ...SellS101.651,040105,71615,64616.7 K to 15.6 K (-6.23 %)
Dec 02 2019ICPTINTERCEPT PHARMACE ...Weyer ChristianEVP, Research & Dev ...BuyM58.74523,05416,68616.6 K to 16.7 K (+0.31 %)
Dec 02 2019ICPTINTERCEPT PHARMACE ...Weyer ChristianEVP, Research & Dev ...BuyM59.1287551,73016,63415.8 K to 16.6 K (+5.55 %)
Nov 27 2019ICPTINTERCEPT PHARMACE ...Weyer ChristianEVP, Research & Dev ...Option ExerciseM58.741066,2262,989
Nov 27 2019ICPTINTERCEPT PHARMACE ...Weyer ChristianEVP, Research & Dev ...Option ExerciseM59.124,267252,26518,983
Nov 27 2019ICPTINTERCEPT PHARMACE ...Weyer ChristianEVP, Research & Dev ...Option ExerciseM58.741056,1683,095
Nov 27 2019ICPTINTERCEPT PHARMACE ...Weyer ChristianEVP, Research & Dev ...Option ExerciseM59.121,750103,46023,250
Nov 27 2019ICPTINTERCEPT PHARMACE ...Weyer ChristianEVP, Research & Dev ...SellS100.004,373437,30015,75920.1 K to 15.8 K (-21.72 %)
Nov 27 2019ICPTINTERCEPT PHARMACE ...Weyer ChristianEVP, Research & Dev ...BuyM58.741066,22620,13220 K to 20.1 K (+0.53 %)
Nov 27 2019ICPTINTERCEPT PHARMACE ...Weyer ChristianEVP, Research & Dev ...BuyM59.124,267252,26520,02615.8 K to 20 K (+27.08 %)
Nov 27 2019ICPTINTERCEPT PHARMACE ...Weyer ChristianEVP, Research & Dev ...SellS100.001,855185,50015,75917.6 K to 15.8 K (-10.53 %)
Nov 27 2019ICPTINTERCEPT PHARMACE ...Weyer ChristianEVP, Research & Dev ...BuyM58.741056,16817,61417.5 K to 17.6 K (+0.60 %)
Nov 27 2019ICPTINTERCEPT PHARMACE ...Weyer ChristianEVP, Research & Dev ...BuyM59.121,750103,46017,50915.8 K to 17.5 K (+11.10 %)
Nov 19 2019ICPTINTERCEPT PHARMACE ...Weyer ChristianEVP, Research & Dev ...SellS85.001,550131,75015,75917.3 K to 15.8 K (-8.95 %)
Nov 19 2019ICPTINTERCEPT PHARMACE ...Weyer ChristianEVP, Research & Dev ...SellS85.001,550131,75015,75917.3 K to 15.8 K (-8.95 %)
Nov 15 2019ICPTINTERCEPT PHARMACE ...Weyer ChristianEVP, Research & Dev ...SellS85.0094680,41017,30918.3 K to 17.3 K (-5.18 %)
Oct 03 2019ICPTINTERCEPT PHARMACE ...Weyer ChristianEVP, Research & Dev ...Payment of ExerciseF65.87463,03018,25518.3 K to 18.3 K (-0.25 %)
Aug 29 2019ICPTINTERCEPT PHARMACE ...Weyer ChristianEVP, Research & Dev ...Payment of ExerciseF60.5035721,59918,30118.7 K to 18.3 K (-1.91 %)
Aug 29 2019ICPTINTERCEPT PHARMACE ...Weyer ChristianEVP, Research & Dev ...Payment of ExerciseF60.5035721,59918,30118.7 K to 18.3 K (-1.91 %)
Jul 03 2019ICPTINTERCEPT PHARMACE ...Weyer ChristianEVP, Research & Dev ...Payment of ExerciseF79.17463,64218,65818.7 K to 18.7 K (-0.25 %)
May 29 2019ICPTINTERCEPT PHARMACE ...Weyer ChristianEVP, Research & Dev ...Payment of ExerciseF87.8335731,35518,70419.1 K to 18.7 K (-1.87 %)
Apr 03 2019ICPTINTERCEPT PHARMACE ...Weyer ChristianEVP, Research & Dev ...Payment of ExerciseF111.50465,12919,06119.1 K to 19.1 K (-0.24 %)
Mar 01 2019ICPTINTERCEPT PHARMACE ...Weyer ChristianEVP, Research & Dev ...SellS103.1633334,35219,10719.4 K to 19.1 K (-1.71 %)
Mar 01 2019ICPTINTERCEPT PHARMACE ...Weyer ChristianEVP, Research & Dev ...Payment of ExerciseF92.7636433,76519,44019.8 K to 19.4 K (-1.84 %)
Jan 18 2019ICPTINTERCEPT PHARMACE ...Weyer ChristianEVP, Research & Dev ...Option ExerciseA110.806,800753,4406,800
Jan 18 2019ICPTINTERCEPT PHARMACE ...Weyer ChristianEVP, Research & Dev ...GrantA0.004,200019,80415.6 K to 19.8 K (+26.92 %)
Jan 03 2019ICPTINTERCEPT PHARMACE ...Weyer ChristianEVP, Research & Dev ...Payment of ExerciseF100.7921521,67015,60415.8 K to 15.6 K (-1.36 %)
Nov 29 2018ICPTINTERCEPT PHARMACE ...Weyer ChristianEVP, Research & Dev ...SellS113.781,343152,80715,81917.2 K to 15.8 K (-7.83 %)
Nov 29 2018ICPTINTERCEPT PHARMACE ...Weyer ChristianEVP, Research & Dev ...Payment of ExerciseF108.661,438156,25317,16218.6 K to 17.2 K (-7.73 %)
Feb 22 2018ICPTINTERCEPT PHARMACE ...Weyer ChristianEVP Research and De ...Option ExerciseA58.743,200187,9683,200
Feb 22 2018ICPTINTERCEPT PHARMACE ...Weyer ChristianEVP Research and De ...GrantA0.002,100018,60016.5 K to 18.6 K (+12.73 %)
Dec 11 2017ICPTINTERCEPT PHARMACE ...Weyer ChristianEVP Research and De ...Option ExerciseA59.1225,0001,478,00025,000
Dec 11 2017ICPTINTERCEPT PHARMACE ...Weyer ChristianEVP Research and De ...GrantA0.0016,500016,5000 to 16.5 K

Page:   1

Contact us | Follow us on Twitter